Europe genital herpes treatment market was valued at $958.5 million in 2022 and will grow by 4.1% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 35 tables and 45 figures, this 111-page report "Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire Europe genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• HSV-1
• HSV-2
Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs
By Route of Administration, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral
• Topical
• Injection
By Patient Gender, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Female
• Male
By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of Europe Market by Virus Type 40
3.1 Market Overview by Virus Type 40
3.2 HSV-1 42
3.3 HSV-2 43
4 Segmentation of Europe Market by Drug Type 44
4.1 Market Overview by Drug Type 44
4.2 Acyclovir 46
4.3 Valacyclovir 47
4.4 Famciclovir 48
4.5 Other Drugs 49
5 Segmentation of Europe Market by Route of Administration 51
5.1 Market Overview by Route of Administration 51
5.2 Oral 53
5.3 Topical 54
5.4 Injection 55
6 Segmentation of Europe Market by Patient Gender 56
6.1 Market Overview by Patient Gender 56
6.2 Female 58
6.3 Male 59
7 Segmentation of Europe Market by Distribution Channel 60
7.1 Market Overview by Distribution Channel 60
7.2 Retail Pharmacies 62
7.3 Hospital Pharmacies 63
7.4 Online Pharmacies 64
7.5 Drug Stores 65
8 European Market 2022-2032 by Country 66
8.1 Overview of European Market 66
8.2 Germany 69
8.3 U.K. 71
8.4 France 73
8.5 Spain 75
8.6 Italy 77
8.7 Netherlands 79
8.8 Rest of European Market 81
9 Competitive Landscape 83
9.1 Overview of Key Vendors 83
9.2 New Product Launch, Partnership, Investment, and M&A 86
9.3 Company Profiles 87
Abbott 87
ADLEY FORMULATIONS 89
Aurobindo Pharma Ltd. 90
Avet Pharmaceuticals Inc. 91
Bausch Health Companies 92
Centurion Remedies 93
Cipla Ltd. 94
Eli Lilly & Company 95
Finecure Pharmaceuticals 96
GlaxoSmithKline Plc 97
Glenmark Pharmaceuticals 98
Macleods Pharmaceuticals 99
Medico Remedies 100
Merck & Co., Inc. 101
Novartis AG 102
Pfizer 103
Reddy's Laboratories 104
Sanofi SA 105
Teva Pharmaceutical Industries Ltd. 106
Torrent Pharma 107
Viatris Inc. 108
Zeelab Pharmacy 109
Zydus Pharmaceuticals, Inc. 110
RELATED REPORTS 111
Market Overview
The Europe Banking as a Service (BaaS) Market is set to experience significant growth from 2024 to 2034, driven by the rapid digital transformation of the financial sector, the increasing adoption of embedded finance solutions, and the rising demand for seamless customer...
Market Overview
The Europe Perfume Packaging Market is poised for substantial growth from 2024 to 2034, fueled by rising consumer demand for premium fragrances, evolving aesthetic preferences, and the growing emphasis on sustainable packaging solutions. The market is projected to achiev...
Market Overview
The Europe Alternate Marine Power (AMP) Market is set to witness remarkable growth from 2024 to 2034, driven by stringent environmental regulations, increasing adoption of green maritime technologies, and the pressing need to reduce greenhouse gas (GHG) emissions in the ...
Market Overview
The Europe Bio Vanillin Market is poised for significant growth from 2024 to 2034, driven by rising consumer preference for natural and sustainable food ingredients, stringent regulatory measures against synthetic additives, and increasing applications in diverse industr...
Market Overview
The Europe AI-Enabled Biometric Market is expected to experience substantial growth from 2024 to 2034, driven by the rising demand for enhanced security systems, increasing adoption of artificial intelligence (AI) technologies, and the need for more efficient biometric i...
Market Overview
The Europe Commercial Vehicle Telematics Market is set to experience robust growth from 2024 to 2034, driven by the increasing adoption of connected technologies, enhanced fleet management solutions, and the need for real-time data analytics across commercial vehicle ope...
Market Overview
The Europe Passive Optical Network (PON) Market is anticipated to experience significant growth from 2024 to 2034, driven by the increasing demand for high-speed internet, data services, and the transition towards fiber-based broadband solutions. As fiber-optic networks ...
Market Overview
The Asia Pacific Safety Valves Market is expected to witness substantial growth from 2024 to 2034, driven by increasing industrial activities and the rising demand for enhanced safety standards across key sectors. The market is projected to reach USD XX.XX billion by 203...
Market Overview
The Europe Safety Valves Market is projected to witness steady growth from 2024 to 2034, driven by rising demand across critical industries such as oil and gas, energy and power, and water treatment. With increased focus on safety and regulatory compliance, the market is...
Market Overview
The North America Safety Valves Market is anticipated to grow significantly from 2024 to 2034, driven by increasing demand across key industries such as oil & gas, energy & power, and water & wastewater treatment. Projected to reach USD XXX.XX million by 2034 from USD XX...